NCM · Financial Statements

Intensity Therapeutics, Inc. (INTS) Financial Statements

$3.25 NCM: INTS Market Cap $8.78M

Intensity Therapeutics, Inc. most recently reported annual revenue of $0, a net loss of $12.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Intensity Therapeutics, Inc.: net profit was positive in 0 of 7 reported years; the most recent year shows a net loss of $12.0M.

Income Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Revenue$0$0$0$0$0$0$0
Operating Expenses$6.0M$6.0M$8.0M$8.0M$8.0M$17.0M$12.0M
Operating Profit$-6.0M$-6.0M$-8.0M$-8.0M$-8.0M$-17.0M$-12.0M
Operating Margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Other Income$0$0$0$0$-2.0M$0$0
Interest$0$0$0$0$0$0$0
Depreciation$0$0$0$0$0$0$0
Profit Before Tax$-5.0M$-6.0M$-8.0M$-8.0M$-11.0M$-16.0M$-12.0M
Tax$0$0$0$0$0$0$0
Net Profit$-5.0M$-6.0M$-8.0M$-8.0M$-11.0M$-16.0M$-12.0M
EPS$-39.50$-44.25$-58.00$-55.50$-34.50$-29.25$-8.56
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Operating Expenses$2.0M$3.0M$5.0M$5.0M$4.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Operating Profit$-2.0M$-3.0M$-5.0M$-5.0M$-4.0M$-3.0M$-3.0M$-3.0M$-3.0M$-3.0M$-3.0M$-3.0M
Operating Margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-2.0M$-3.0M$-5.0M$-5.0M$-4.0M$-3.0M$-3.0M$-3.0M$-3.0M$-3.0M$-2.0M$-3.0M
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$-2.0M$-3.0M$-5.0M$-5.0M$-4.0M$-3.0M$-3.0M$-3.0M$-3.0M$-3.0M$-2.0M$-3.0M
EPS$-4.25$-5.75$-8.50$-9.00$-6.25$-5.50$-5.50$-3.25$-1.55$-1.21$-0.96$-1.11

Over the 7 years reported for Intensity Therapeutics, Inc., cash stood at $12.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 6.50 times.

Balance Sheet — 7 Years (USD millions)

Metric2019202020212022202320242025
Total Assets$9.0M$10.0M$5.0M$2.0M$17.0M$5.0M$14.0M
Current Assets$9.0M$9.0M$5.0M$1.0M$15.0M$3.0M$13.0M
Cash$4.0M$9.0M$5.0M$1.0M$9.0M$3.0M$12.0M
Inventory$0$0$0$0$0$0$0
Receivables$0$0$0$0$0$0$0
Fixed Assets$0$0$0$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0$0
Investments$5.0M$0$0$0$6.0M$0$0
Other Assets$0$0$0$0$0$0$0
Total Liabilities$1.0M$12.0M$14.0M$17.0M$4.0M$2.0M$2.0M
Current Liabilities$1.0M$1.0M$4.0M$7.0M$4.0M$2.0M$2.0M
Borrowings$0$0$2.0M$4.0M$0$0$0
Other Liabilities$1.0M$11.0M$12.0M$12.0M$4.0M$2.0M$2.0M
Equity$0$0$0$0$0$0$0
Reserves$8.0M$-2.0M$-9.0M$-15.0M$13.0M$3.0M$12.0M

For Intensity Therapeutics, Inc., operating cash flow was positive in 0 of 7 reported years; free cash flow in the latest year was negative at $9.0M; free cash flow was positive in 0 of 7 years.

Cash Flow Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Operating Cash Flow$-4.0M$-5.0M$-7.0M$-5.0M$-7.0M$-15.0M$-9.0M
Investing Cash Flow$2.0M$5.0M$0$0$-6.0M$6.0M$0
Financing Cash Flow$0$0$0$0$-2.0M$0$0
Net Cash Flow$1.0M$5.0M$-5.0M$-3.0M$7.0M$-6.0M$9.0M
Free Cash Flow$-4.0M$-5.0M$-7.0M$-5.0M$-7.0M$-15.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.02
FCF Yield-96.30%
Quick Ratio5.00
Interest Coverage—
Return 1Y-41.86%
Return 3Y-96.60%
Return 5Y—

Intensity Therapeutics, Inc. (INTS) financials — frequently asked questions

What is Intensity Therapeutics, Inc.'s annual revenue?

Intensity Therapeutics, Inc. (INTS) reported annual revenue of $0 in its most recent fiscal year.

What is Intensity Therapeutics, Inc.'s net profit?

Intensity Therapeutics, Inc. (INTS) reported a net loss of $12.0M in its most recent fiscal year.

What is INTS EV/EBITDA?

Intensity Therapeutics, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 0.02.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
INTS Overview INTS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.